Results 111 to 120 of about 10,401 (200)
A esofagite eosinofílica constitui uma doença infl amatória do esófago, mundialmente emergente, caracterizada pela infiltração significativa e isolada da mucosa esofágica por eosinófilos.
Gaspar, A, Piedade, S
core
Eosinophile Ösophagitis: Die Sicht des Gastroenterologen [PDF]
Zusammenfassung: Die eosinophile Ösophagitis ist charakterisiert durch Symptome ösophagealer Dysfunktion (meist Dysphagie) und eosinophile Entzündungsinfiltrate im Ösophagus.
Schoepfer, A.
core
Bronchial thermoplasty: implementing best practice in the era of cost containment. [PDF]
Increasing dependence on advanced technologies in the 21st century has created a dilemma between the practice and business of medicine. From information technology to robotic surgery, new technologies have expanded treatment possibilities and have ...
Kenyon, Nicholas +3 more
core
Background: REMIT is the first real-world study of mepolizumab effectiveness in patients with severe asthma (SA) in Taiwan. Objectives: The primary objective evaluated changes in clinically significant exacerbations (CSEs; defined as use of oral ...
Shih-Lung Cheng +19 more
doaj +1 more source
Background: Retrospective data are limited on the effectiveness of mepolizumab treatment that is reflective of real-world practice in patients with chronic rhinosinusitis with nasal polyps (CRSwNP).
Juan Carlos Cardet, MD, MPH +10 more
doaj +1 more source
Care pathways for the selection of a biologic in severe asthma [PDF]
Bousquet, Jean +12 more
core +2 more sources
Background: Mepolizumab is an effective treatment for severe eosinophilic asthma, leading to a depletion of blood eosinophil levels, the clinical relevance of which remains unclear.
Matteo Bonato +5 more
doaj +1 more source
Background The advent of biologics has resulted in major progress in the treatment of severe T2 high asthmatics. There are currently several classes of biologics approved for severe asthma including anti-immunoglobulin E, anti-interleukin-5/interleukin ...
M. Sabbe +3 more
doaj +1 more source
Background and Objectives: Real-life data on the efficacy of biologic agents (BAs) on asthma-comorbid CRSwNP are needed. Our primary goal is to investigate the effects of BAs on CRSwNP symptoms, as well as endoscopic and tomography scores.
Meryem Demir +17 more
doaj +1 more source
Corrado Pelaia,1 Alessandro Vatrella,2 Maria Teresa Busceti,1 Luca Gallelli,3 Rosa Terracciano,3 Rocco Savino,3 Girolamo Pelaia1 1Department of Medical and Surgical Sciences, Section of Respiratory Diseases, University “Magna Græcia&rdquo ...
Pelaia C +6 more
doaj

